Econostrum on MSN
Major recall of FreeStyle Libre devices: How this could impact your diabetes treatment
The decision to recall approximately three million sensors follows reports of potentially life-threatening errors in the ...
1don MSN
Abbott issues ‘urgent' message to patients after medical devices linked to 700 injuries, 7 deaths
The Food and Drug Administration issued an alert about a “potentially high-risk issue” regarding malfunctioning Abbott ...
Editor’s Note: This article originally appeared on Abbott’s website. ABBOTT PARK, Ill., May 31, 2018 /PRNewswire/ — Abbott (NYSE: ABT) announced today the launch of its Afinion™ 2 analyzer in ...
Anew alert from the U.S. Food and Drug Administration has warned that some Libre sensors from Abbott may give incorrect blood ...
Though continuous glucose monitors have long been more widely used among people with Type 1 diabetes, new research has increasingly shown that the Type 2 population can majorly benefit from CGM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback